₹461.0
+0.34% today
· 30d -12.02%
as of 2026-09-04
Price · Daily Candles
“Rossari Biotech: Q4 profit surge as DIIs trim holdings amid weak growth outlook.”
Rossari Biotech reported a Q4 net profit increase of +33.45% YoY to ₹46 Cr, alongside an 18.17% YoY revenue growth to ₹685 Cr. However, the stock has underperformed, down -18.5% over the past year, with ML predictions indicating mostly weak to neutral sales and EBIT growth for the upcoming periods.
BULL CASE
+Quarterly net profit surged +33.45% YoY to ₹46 Cr in Q4 2026, with revenue up +18.17% YoY to ₹685 Cr.
+The 5-year CAGR for revenue stands strong at 27.57%, while net profit CAGR is 13.26% over the same period.
+The stock is currently trading at a TTM P/E of 20.2, significantly lower than the sector average and peers like FLUOROCHEM (76.13) and ASIANPAINT (69.19).
+Current price ₹540.6 is 44.16% above its 52-week low of ₹375.0, suggesting some recent recovery from year-long declines.
BEAR CASE
−The free cash flow is negative ₹200 Cr, translating to a -6.63% FCF yield, indicating significant cash burn.
−Share price has fallen -18.5% over the last year and is -29.43% off its 52-week high of ₹766.0.
−DIIs reduced their stake by -0.06% QoQ to 18.2% as of March 2026, while FIIs also decreased holdings by -0.15% to 2.18%.
−ML growth predictions for EBIT and sales over the next year generally range from weak to neutral (ranks of 0.48 to 0.562).
⟳ What Changed
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹697 Cr
+28.23% YoY
NET PROFIT
₹35 Cr
+4.46% YoY
OPM
11.97%
-0.71pp YoY
EPS
₹6.34
PE 20.2
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-7.8% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
Rossari Biotech trades at a TTM P/E of 20.2 and ROCE of 15.0%, positioning it at a discount to peers like Asian Paints (P/E 69.19, ROCE 28.61%) and Pidilite Industries (P/E 61.45, ROCE 30.22%), but on par with FluoroChem's ROCE (15.03%).
PEERPEROCE %
ROSSARI20.215.0
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒
48
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
UNDERPERFORMER
20
Valuation
REASONABLE
60
Growth
STEADY
58
Profitability
DECENT
68
Technicals
WEAK
30
Risk
MODERATE
50
Key Stats
TTM PE
20.2
P/B
2.26
52W HIGH
₹690.3
OFF HIGH
-33.22%
DIV YIELD
0.09%
MKT CAP
₹2568 Cr
◉ Active Signals
MACDBearish-3.8843
RSI(14)Bearish30.95
Street Consensus
4 analysts₹601.75
mean target
Low ₹570.0Now ₹461.0High ₹637.0
⧉ Strategy Fit 🔒